Core Insights - Henry Schein One has launched AI-driven Image Verify, enhancing its dental practice management systems [1] - This innovation is part of a series of product advancements aimed at achieving a "Clean Claims" vision in dentistry [1] - Image Verify is integrated into Dentrix and Dentrix Ascend, streamlining the claims submission process for dental practices [1]

Key Takeaways HSIC is set to report Q4 2025 results on Feb. 24, with revenues projected to rise 4.5% year over year.Henry Schein's Global Specialty Products revenues are expected to grow 5.9% on implant strength.HSIC's Global Technology sales are projected to jump 9.7% on SaaS and cloud momentum.Henry Schein, Inc. (HSIC) is scheduled to release fourth-quarter 2025 results on Feb. 24, before the opening bell.In the last reported quarter, the company posted adjusted earnings per share (EPS) of $1.38, which su ...

Founded in 1932, Melville, New York-based Henry Schein, Inc. (HSIC) provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. The company has a market capitalization of $9.2 billion and operates through Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology segments. The company's shares have underperformed the broader market over the past year but have slightly outperformed in 2026. HSIC sto ...

Core Insights - The American Dental Association Foundation (ADAF) is launching Give Kids A Smile® (GKAS) 2026 at UTHealth Houston School of Dentistry, celebrating 24 years of improving children's access to oral health care [1] - GKAS has grown from a local initiative in St. Louis, MO, to a national movement, having provided services to over 10.2 million underserved children since its inception in 2003 [1] - The national GKAS initiative will commence in February, coinciding with National Children's Dental Health Month [1]

Core Viewpoint - Henry Schein, Inc. will release its fourth quarter 2025 financial results on February 24, 2026, before the stock market opens, and will host a live webcast of its earnings conference call at 8:00 a.m. Eastern time on the same day [1] Company Announcement - The financial results announcement is scheduled for February 24, 2026, before market opening [1] - A live webcast of the earnings conference call will take place at 8:00 a.m. Eastern time on the same day [1] - Stanley M. Bergman, Chairman of the Board, will be among the speakers during the conference call [1]

Core Insights - Henry Schein, Inc. (HSIC) is a healthcare products and services distributor with a market cap of $9.4 billion, providing a wide range of products and solutions to healthcare providers [1] - The company is expected to report a profit of $1.30 per share for fiscal Q4 2025, reflecting a 9.2% increase from $1.19 per share in the same quarter last year [2] - For the current fiscal year ending in December, HSIC is projected to report a profit of $4.91 per share, up 3.6% from $4.74 per share in fiscal 2024, with further growth expected to $5.27 in fiscal 2026 [3] Performance Comparison - HSIC shares have increased by 11.5% over the past 52 weeks, lagging behind the S&P 500 Index's return of 16.9%, but outperforming the State Street Health Care Select Sector SPDR ETF's increase of 10.4% [4] - On December 9, HSIC shares rose 2.2% after Barclays analyst initiated coverage with an "Overweight" rating and an $86 price target, citing a favorable growth outlook [5] Analyst Sentiment - Wall Street analysts have a "Moderate Buy" rating for HSIC, with six recommending "Strong Buy," nine advising "Hold," and one indicating "Strong Sell" [6] - The current trading price is above the mean price target of $77.64, with a Street-high price target of $90 suggesting a potential upside of 12.5% from current levels [6]

Group 1 - Upslope Capital Management aims to provide attractive, equity-like returns while reducing market risk and maintaining low correlation with traditional equity strategies [1] - The Fund delivered a return of +2.0% (net) in Q4 2025, outperforming the S&P Midcap 400 ETF and HFRX Equity Hedge Index, which returned +1.6% [1] - For the full year 2025, the Fund achieved a return of +14.8%, significantly higher than the +7.2% and +10.1% returns of the respective indexes [1] Group 2 - Henry Schein, Inc. (NASDAQ:HSIC) has been added to Upslope's portfolio, with a recent stock price of $79.98 per share as of January 16, 2026 [2] - The one-month return for Henry Schein, Inc. was 3.09%, and its shares increased by 9.23% over the last 52 weeks [2] - Henry Schein, Inc. is the leading distributor of dental products in the U.S. and holds a significant market share in various countries, with 52% of Dental sales from the U.S. [3]

Group 1 - The article does not provide any relevant content regarding company or industry insights [1]

Core Insights - Henry Schein has outlined its roadmap for 2026, focusing on improving profitability and expanding high-margin businesses at the J.P. Morgan Healthcare Conference [1] Company Strategy - The company is a leading provider of medical products, equipment, and services in alternative care and home care markets, emphasizing shifts in healthcare delivery while tightening operational costs [2] - Henry Schein aims to achieve more than $200 million in operating income improvements over the next few years through lower costs and higher gross margins [5] - The long-term strategy, BOLD +1, targets 50% of non-GAAP operating income from high-growth, high-margin businesses by the end of 2027, with an additional 10% from corporate brands [6] Market Trends - Patient traffic is rising in the medical market, with a shift towards outpatient care and increased demand for chronic disease management and preventative healthcare, leading to expected mid-single digit growth in the medical sector [3] Financial Performance - The company reports strong cash flow, with a non-GAAP earnings per diluted share compound annual growth rate of 6.2% [4] Management Changes - A significant announcement at the J.P. Morgan Healthcare Conference was the change in management, with Fred Lowery set to become CEO effective March 2, 2026 [7]

Core Viewpoint - Henry Schein has announced the appointment of Fred Lowery as the new CEO, effective March 2 of this year, following a thorough succession planning process that included both internal and external candidates [3]. Group 1: Leadership Transition - The company has undergone a succession recruiting process, which was well-received with significant interest from external candidates as well as internal candidates [3]. - The previous CEO, Stanley Bergman, announced his retirement plans in July, initiating the search for a successor [3]. Group 2: Conference Presentation - The presentation at the conference included key members of the Henry Schein management team, indicating a collaborative approach to leadership and communication with stakeholders [1][2]. - The management team aims to allocate sufficient time for Q&A following the presentation, emphasizing transparency and engagement with the audience [1].